[1]
|
Mohanakrishnan, P., Fowler, A.H., Vonsattel, J.P., Husain, M.M., Jolles, P.R., Liem, P. and Komoroski, R.A. (1995) An in vitro ?H nuclear magnetic resonance study of the tempoparietal cortex of Alzheimer brains. Experimental Brain Research, 102, 503-510.
doi:10.1007/BF00230654
|
[2]
|
Kennedy, A.M., Frackowiak, R.S., Newman, S.K., Bloomfield, P.M., Seaward, J., Roques, P., Lewington, G., Cunningham, V.J. and Rossor, M.N. (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer’s disease. Neuroscience Letters, 186, 17-20.
doi:10.1016/0304-3940(95)11270-7
|
[3]
|
Volz, H.R., Riehemann, S., Maurer, I., Smesny, S., Sommer, M., Rzanny, R., Holstein, W., Czekalla, J. and Sauer, H. (2000) Reduced phosphodiesters and high- energy phosphates in the frontal lobe of schizophrenic patients: A 31P chemical shift spectroscopic-imaging study. Biological Psychiatry, 47, 954-961.
doi:10.1016/S0006-3223(00)00235-3
|
[4]
|
Maurer, I., Zierz, S. and Moller, H.-J. (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophrenia Research, 48, 125-136.
doi:10.1016/S0920-9964(00)00075-X
|
[5]
|
Fukuzako, H. (2001) Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. The World Journal of Biological Psychiatry, 2, 70-82. doi:10.3109/15622970109027496
|
[6]
|
Jou, S.-H., Chiu, N.-Y. and Liu, C.-S. (2009) Mitochondrial dysfunction and psychiatric disorders. Chang Gung Medical Journal, 32, 370-379.
|
[7]
|
Buchsbaum, M.S. and Hazlett, E.A. (1998) Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophrenia Bulletin, 24, 343-364.
|
[8]
|
Cavelier, L., Jazin, E.E., Eriksson, I., Prince, J., Bave, U., Oreland, L. and Gyllensten, U. (1995) Decreased cytochrome c-oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics, 29, 217-224.
doi:10.1006/geno.1995.1234
|
[9]
|
Shao, L., Martin, M.V., Watson, S.J., Schatzberg, A., Akil, H., Myers, R.M., Jones, E.G., Bunney, W.E. and Vawter, M.P. (2008) Mitochondrial involvement in psychiatric disorders. Annals of Medicine, 40, 281-295.
|
[10]
|
Mann, V.M., Cooper, J.M., Krige, D., Daniel, S.E., Schapira, A.H.V. and Marsden, C.D. (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Рarkinson’s disease. Brain, 115, 333-342.
|
[11]
|
Dror, N., Klein, E., Karry, R., Sheinkman, A., Kirsh, Z., Mazor, M., Tzukerman, M. and Ben-Shachar D. (2002) State-dependent alterations in mitochondrial complex I activity in platelets: A potential peripheral marker for schizophrenia. Molecular Psychiatry, 7, 995-1001.
|
[12]
|
B?hm, M., Papezova, H., Hansikova, H., Wenchich, L. and Zeman, J. (2007) Activities of respiratory chain complexes in isolated platelets in females with anorexia nervosa. International Journal of Eating Disorders, 40, 659-663.
doi:10.1002/eat.20403
|
[13]
|
Ben-Shachar, D. and Klein, E. (2008) Methods and kits for diagnosis of schizophrenia. US Patent, 7, 442-496.
|
[14]
|
Valla, J., Schneider, L., Niedzielko, T., Coon, K.D., Caselli, R., Sabbagh, M.N., Ahern, G.L., Baxter, L., Alexander, G., Walker, D.G. and Reiman, E.M. (2006) Impaired platelet mitochondrial activity in Alzheimer’s disease and mild cognitive impairment. Mitochondrion, 6, 323-330.
|
[15]
|
Burbaeva, G.Sh., Boksha, I.S., Turishcheva, M.S., Tereshkina, E.B., Savushkina, O.K., Starodubtseva, L.I., Fedorova, Ya.B. and Gavrilova, S.I. (2008) Cytochrome c- oxidase and glutamine synthetase-like protein in blood platelets as candidates for the role of early markers of Alzheimer’s disease. Proceedings of the IV-th Scientific and Practical Conference “Alzheimer’s disease and cognitive impairments in old age: Advances in neurobiology and therapy”, 89-97 [Russian].
|
[16]
|
Boksha, I., Burbaeva, G., Savushkina, O., Tereshkina, E., Turishcheva, M., Starodubtseva, L. and Vorobyeva, E. (2009) Blood proteins as markers and predictors of cognitive deficit in mental pathologies. Abstracts, 3rd World Congress Gene-2009, Foshan, China.
http://www.bitlifesciences.com/wcg2009/Program.asp
|
[17]
|
Benecke, R., Strümper, P. and Weiss, H. (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116, 1451-1463.
doi:10.1093/brain/116.6.1451
|
[18]
|
Parker, W.D. Jr and Parks, J.K. (1995) Cytochrome c- oxidase in Alzheimer’s disease brain: purification and characterization. Neurology, 45, 482-486.
|
[19]
|
Cardoso, S.M., Proenca, M.T., Santos, S., Santana, I. and Oliveira, C.R. (2004) Cytochrome c-oxidase is decreased in Alzheimer’s disease platelets. Neurobiology of Aging, 25, 105-110. doi:10.1016/S0197-4580(03)00033-2
|
[20]
|
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry, 193, 265- 275.
|
[21]
|
Kato, T. (2001) The other, forgotten genome: Mitochondrial DNA and mental disorders. Molecular Psychiatry, 6, 625-633. doi:10.1038/sj.mp.4000926
|
[22]
|
Washizuka, S., Iwamoto, K., Kakiuchi, C., Bundo, M. and Kato, T. (2009) Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neuroscience Research, 63, 199-204.
doi:10.1016/j.neures.2008.12.004
|
[23]
|
Maurer, I. and Moller, H.J. (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Molecular and Cellular Biochemistry, 174, 255-259.
doi:10.1023/A:1006872911332
|
[24]
|
Streck, E.L., Rezin, G.T., Barbosa, L.M., Assis, L.C., Grandi, E. and Quevedo, J. (2007) Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn-Schmiedeberg’s Archives of Pharmacology, 376, 127-133.
doi:10.1007/s00210-007-0178-2
|
[25]
|
Casademont, J., Garrabou, G., Miró, ò., López, S., Pons, A., Bernardo, M. and Cardellach, F. (2007) Neuroleptic treatment effect on mitochondrial electron transport chain: Peripheral blood mononuclear cells analysis in psychotic patients. Journal of Clinical Psychopharmacology, 27, 284-288. doi:10.1097/JCP.0b013e318054753e
|
[26]
|
Burbaeva, G.Sh., Boksha, I.S., Tereshkina, E.B., Savushkina, O.K., Turishcheva, M.S., Starodubtseva, L.I., Brusov, O.S. and Morozova, M.A. (2006) Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia. The World Journal of Biological Psychiatry, 7, 75-81. doi:10.1080/15622970510029957
|
[27]
|
Wechsler, D. (1981) Wechsler adult intelligence scale- revised,San Antonio, TX: Psychological Corporation.
|
[28]
|
Marder, S.R., Davis, J.M. and Chouinard, G. (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. The Journal of Clinical Psychiatry, 58, 538-546. doi:10.4088/JCP.v58n1205
|